Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Telomir Pharmaceuticals, Inc. - Common Stock (NQ: TELO ) 4.220 +0.030 (+0.72%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 41,709 Open 4.110 Bid (Size) 4.210 (2) Ask (Size) 4.220 (1) Prev. Close 4.190 Today's Range 4.105 - 4.230 52wk Range 3.110 - 20.72 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News BioMedNewsBreaks — Telomir Pharmaceuticals (NASDAQ: TELO), Science of Longevity Featured in Upcoming Episode of “Health Uncensored with Dr. Drew” September 27, 2024 Via Investor Brand Network Telomir Pharmaceuticals Special Advisor Dr. Michael Roizen to Discuss Telomir-1 and the Science of Longevity on Health Uncensored With Dr. Drew on the Fox Business Network This Sunday September 26, 2024 Via ACCESSWIRE Performance YTD -15.60% -15.60% 1 Month -12.63% -12.63% 3 Month -1.63% -1.63% 6 Month -38.93% -38.93% 1 Year -15.60% -15.60% More News Read More Telomir Pharmaceuticals (NASDAQ: TELO) Featured In Local ABC Exclusive Showing Positive Outcomes Of Proposed Age Reversal Pill In Dogs September 05, 2024 Via News Direct BioMedNewsBreaks – Telomir Pharmaceuticals Inc. (NASDAQ: TELO) Appoints Pharmaceutical Innovation Veteran as Chief Scientific Advisor September 04, 2024 Via Investor Brand Network Exposures Product Safety Telomir Pharmaceuticals Featured in Local ABC Exclusive Showing Positive Outcomes of Proposed Age Reversal Pill in Dogs August 20, 2024 Via ACCESSWIRE Telomir Pharmaceuticals Appoints Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo (Now Sanofi-Aventis), to Lead IND and INAD Applications for Human and Veterinary Indications September 04, 2024 Via ACCESSWIRE Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session August 19, 2024 Via Benzinga TELO Stock Earnings: Telomir Pharmaceuticals Reported Results for Q2 2024 August 13, 2024 Via InvestorPlace From Pets To Humans, Telomir Pharmaceuticals (NASDAQ: TELO) Holds The Key To Extending Life, Reversing Aging May 31, 2024 Via News Direct TELO Stock Earnings: Telomir Pharmaceuticals Reported Results for Q1 2024 May 13, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's After-Market Session April 30, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session April 22, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session April 10, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session March 14, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session March 12, 2024 Via Benzinga Why Herbalife Shares Are Trading Lower By Around 36%? Here Are Other Stocks Moving In Thursday's Mid-Day Session February 15, 2024 Via Benzinga Why AppLovin Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket February 15, 2024 Via Benzinga Cisco Issues Weak Outlook, Joins Fastly, Herbalife And Other Big Stocks Moving Lower In Thursday's Pre-Market Session February 15, 2024 Via Benzinga Topics Stocks Exposures US Equities Gilead-Backed Kyverna Overshoots Raised IPO Expectations February 11, 2024 Via Talk Markets Topics Initial Public Offering Exposures Securities Market Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
